[{"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-45547.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-1589240.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-5951073.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-43114.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":546061.0,"ProceedsFromWarrantExercises_2_Q2_USD":1000000.0,"OperatingLeasesRentExpenseNet_1_Q2_USD":89675.0,"OperatingLeasesRentExpenseNet_2_Q2_USD":182054.0,"OperatingLeasesFutureMinimumPaymentsDueThereafter_0_Q2_USD":828205.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q2_USD":338345.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q2_USD":348495.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q2_USD":298305.0,"OperatingLeasesFutureMinimumPaymentsDueInFiveYears_0_Q2_USD":246004.0,"OperatingLeasesFutureMinimumPaymentsDueCurrent_0_Q2_USD":165317.0,"AccountsPayableRelatedPartiesCurrent_0_Q2_USD":null,"OperatingLeasesFutureMinimumPaymentsDue_0_Q2_USD":1930982.0,"NonoperatingIncomeExpense_2_Q2_USD":-542740.0,"Goodwill_0_Q2_USD":11640000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":15154.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":15154.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":15154.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q2_USD":31369.0,"BusinessCombinationContingentConsiderationLiability_0_Q2_USD":4317000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":4317000.0,"PrepaidExpenseCurrent_0_Q2_USD":433630.0,"IncreaseDecreaseInAccountsPayableRelatedParties_2_Q2_USD":-100000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":84408.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":84407.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":82237.0,"NonoperatingIncomeExpense_1_Q2_USD":1097952.0,"GainsLossesOnExtinguishmentOfDebt_1_Q2_USD":135000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-5803708.0,"DepreciationDepletionAndAmortization_2_Q2_USD":43148.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_1_Q2_USD":-131291.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_2_Q2_USD":147365.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0399,"OperatingLeaseRightOfUseAsset_0_Q2_USD":1833933.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":1669855.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":261127.0,"OperatingLeaseLiability_0_Q2_USD":1930982.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q2_USD":154824000.0,"ForeignCurrencyTransactionGainLossRealized_1_Q2_USD":-137448.0,"ForeignCurrencyTransactionGainLossRealized_2_Q2_USD":149307.0,"FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_2_Q2_USD":-1314.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":7576.0,"EquityFairValueAdjustment_2_Q2_USD":860000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-1720531.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":8626677.0,"OtherReceivablesNetCurrent_0_Q2_USD":2998.0,"DepositsAssetsNoncurrent_0_Q2_USD":137550.0,"OtherIndefiniteLivedIntangibleAssets_0_Q2_USD":166464000.0,"IncreaseDecreaseInAccountsAndOtherReceivables_2_Q2_USD":-17796.0,"AccountsPayableTradeCurrent_0_Q2_USD":627980.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":690061.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":924071.0,"InterestIncomeExpenseNet_1_Q2_USD":null,"InterestIncomeExpenseNet_2_Q2_USD":null,"IncreaseDecreaseInOperatingLiabilities_2_Q2_USD":-123313.0,"IncreaseDecreaseInOperatingAssets_2_Q2_USD":-127611.0,"StockIssuedDuringPeriodValueOther_1_Q2_USD":144000.0,"DepreciationDepletionAndAmortization_1_Q2_USD":21667.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q2_USD":4317000.0,"SaleOfStockNumberOfSharesIssuedInTransaction_2_Q2_shares":10000.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":135000.0,"InterestAndOtherIncome_1_Q2_USD":18400.0,"LiabilitiesCurrent_0_Q2_USD":1090095.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":178359885.0,"Liabilities_0_Q2_USD":7076950.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":241661.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":90731.0,"IncomeTaxExpenseBenefit_2_Q2_USD":null,"IncomeTaxExpenseBenefit_1_Q2_USD":null,"GrossProfit_2_Q2_USD":null,"GrossProfit_1_Q2_USD":null,"GeneralAndAdministrativeExpense_2_Q2_USD":4136160.0,"GeneralAndAdministrativeExpense_1_Q2_USD":2235348.0,"EffectOfExchangeRateOnCashAndCashEquivalents_2_Q2_USD":-147365.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.13,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":1000000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.04,"Depreciation_1_Q2_USD":21667.0,"CostOfRevenue_2_Q2_USD":null,"CostOfRevenue_1_Q2_USD":null,"CommonStockValue_0_Q2_USD":4630.0,"CommonStockSharesOutstanding_0_Q2_shares":46303924.0,"CommonStockSharesIssued_0_Q2_shares":46303924.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_2_Q2_USD":-3655547.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":8626677.0,"AssetsNoncurrent_0_Q2_USD":168519891.0,"AssetsCurrent_0_Q2_USD":9063305.0,"Assets_0_Q2_USD":178359885.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":3448473.0,"AdditionalPaidInCapital_0_Q2_USD":229899400.0,"Depreciation_2_Q2_USD":43148.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":878989.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-132321.0,"NetIncomeLoss_1_Q2_USD":-1720531.0,"InterestAndOtherIncome_2_Q2_USD":32953.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":102300.0,"StockIssuedDuringPeriodValueIssuedForServices_2_Q2_USD":0.0,"ShareBasedCompensation_2_Q2_USD":924071.0,"ResearchAndDevelopmentExpense_2_Q2_USD":1081660.0,"ResearchAndDevelopmentExpense_1_Q2_USD":561468.0,"PreferredStockValue_0_Q2_USD":null,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"OperatingIncomeLoss_2_Q2_USD":-5260968.0,"OperatingIncomeLoss_1_Q2_USD":-2818483.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-4375861.0,"OperatingExpenses_2_Q2_USD":5260968.0,"DepreciationAndAmortization_2_Q2_USD":50726.0,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"AccruedLiabilitiesCurrent_0_Q2_USD":200988.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":46258272.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":46275228.0,"StockholdersEquity_0_Q2_USD":171282935.0,"Revenues_2_Q2_USD":null,"Revenues_1_Q2_USD":null,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-58575548.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":776689.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":132321.0,"NetIncomeLoss_2_Q2_USD":-5803708.0,"OperatingExpenses_1_Q2_USD":2818483.0,"SaleOfStockNumberOfSharesIssuedInTransaction_1_Q2_shares":10000.0,"Ticker":"ENOB","CIK":"1527728","name":"ENOCHIAN BIOSCIENCES INC","OfficialName":"Enochian Biosciences Inc. Common Stock","form":"10-Q","period":"20191231","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"398960164.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200210"}]